Cargando…
Regulator combinations identify systemic sclerosis patients with more severe disease
Systemic sclerosis (SSc) is a heterogeneous autoimmune disorder that results in skin fibrosis, autoantibody production, and internal organ dysfunction. We previously identified 4 “intrinsic” subsets of SSc based upon skin gene expression that are found across organ systems. Gene expression regulator...
Autores principales: | Wang, Yue, Franks, Jennifer M., Yang, Monica, Toledo, Diana M., Wood, Tammara A., Hinchcliff, Monique, Whitfield, Michael L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526449/ https://www.ncbi.nlm.nih.gov/pubmed/32721949 http://dx.doi.org/10.1172/jci.insight.137567 |
Ejemplares similares
-
Systems Level Analysis of Systemic Sclerosis Shows a Network of Immune and Profibrotic Pathways Connected with Genetic Polymorphisms
por: Mahoney, J. Matthew, et al.
Publicado: (2015) -
Machine-learning classification identifies patients with early systemic sclerosis as abatacept responders via CD28 pathway modulation
por: Mehta, Bhaven K., et al.
Publicado: (2022) -
Molecular characterization of systemic sclerosis esophageal pathology identifies inflammatory and proliferative signatures
por: Taroni, Jaclyn N., et al.
Publicado: (2015) -
A novel multi-network approach reveals tissue-specific cellular modulators of fibrosis in systemic sclerosis
por: Taroni, Jaclyn N., et al.
Publicado: (2017) -
Molecular Signatures in Skin Associated with Clinical Improvement During Mycophenolate Treatment in Systemic Sclerosis
por: Hinchcliff, Monique, et al.
Publicado: (2013)